Livi®, the First FDA-Cleared After-Sex Absorption Device, Is Now Available
August 19, 2026
Doctor-created Livi addresses a long-overlooked need in post-sex intimate health, available exclusively at MyLivi.com.
Doctor-created Livi addresses a long-overlooked need in post-sex intimate health, available exclusively at MyLivi.com.
The ZEISS CLINIC 360 all-in-one browser-based software solution aggregates clinical data at scale and powers advanced analytics for streamlined ophthalmic workflows, providing clinicians with more time for personalizing patient care.
Touting an “exceptional” gastrointestinal safety profile for its oral obesity drug candidate in a study of healthy volunteers, Enveda plans to test the asset in people stopping GLP-1 treatment.
MIT researchers’ approach, which uses naturally occurring sugars as antifreeze, could make it easier for hospitals to deploy this type of cancer treatment.
Empatica’s platform enables continuous tracking of symptoms such as bradykinesia, dyskinesia and sleep quality.
The approval covers smartSedLine monitor availability in applicable European markets.
WUXI, China, Aug. 19, 2026 /PRNewswire/ — NORROY BIOSCIENCE (NORROY), a clinical-stage biotechnology company focused on innovative targeted radiopharmaceuticals, announced that the U.S. Food and Drug Administration (FDA) has granted both Breakthrough Therapy and Fast Track designations to NORROY’s 68Ga-NYM096, a potential radiopharmaceutical imaging agent targeting carbonic anhydrase Ⅸ (CAⅨ) for PET imaging of clear cell renal cell carcinoma (ccRCC).
BOSTON, Aug. 19, 2026 /PRNewswire/ — Empatica, a leader in digital biomarker development and clinical-grade wearable technology, today announced that the Empatica Health Monitoring Platform for Parkinson’s has received 510(k) clearance from the U.S. Food and Drug Administration (FDA).
Each year, roughly 2% to 5% of the population is affected by mitral valve prolapse (MVP) and mitral regurgitation (MR). These conditions can affect the heart’s rhythm and have been linked to sudden cardiac death, particularly in advanced stages of the disease, through the development of abnormal electrical activity. MVP causes the valve to bend backward as the heart contracts, while MR affects the valve’s ability to close fully, leading to blood leaking backward.
During cancer treatment, the same brain tumor can be treated with the same anticancer drug, but the effect can differ from patient to patient. A Korean research team has developed a chip that recreates a patient’s own tumor cells together with the surrounding peritumoral vascular environment, making it possible to predict patient-specific treatment responses in advance.